Johnson & Johnson has expanded a clinical trial of its experimental coronavirus vaccine to include adolescents 12 to 17 years old, the drugmaker announced Friday.
Johnson & Johnson testing COVID vaccine in adolescents between 12 and 17 years old
NY Daily News - 2 Apr 2021 16:43
Johnson & Johnson has expanded a clinical trial of its experimental coronavirus vaccine to include adolescents 12 to 17 years old, the drugmaker announced Friday.
Share this Article
Recommended